![Stacy Coen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stacy Coen
Corporate Officer/Principal presso
IMMUNOGEN, INC.
Patrimonio netto: 435 $ in data 31/05/2026
Profilo
Stacy A. Coen is Chief Business Officer & Senior Vice President at ImmunoGen, Inc. since 2020.
Current roles also include Member at Massachusetts Biotechnology Council, Trustee at Huntington's Disease Society of America, and Member at Alliance for Regenerative Medicine.
Former positions include Independent Director at FibroBiologics, Inc. from 2021 to 2026, Vice President at Genzyme Corp., and Vice President-Business Development at Editas Medicine, Inc. Education includes undergraduate studies at the University of Massachusetts and an MBA from the University of Virginia Darden School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
FIBROBIOLOGICS, INC. 0,01% | 24/04/2026 | 375 ( 0,01% ) | 435 $ | 31/05/2026 |
Posizioni attive di Stacy Coen
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 03/06/2020 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Corporate Officer/Principal | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Corporate Officer/Principal | - |
Huntington's Disease Society of America | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Stacy Coen
| Società | Posizione | Fine |
|---|---|---|
| FIBROBIOLOGICS, INC. | Direttore/Membro del Consiglio | 22/06/2026 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | - |
Formazione di Stacy Coen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
54
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Huntington's Disease Society of America | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroBiologics, Inc.
 FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
